KMT2A and acute myeloid leukemia: AML is a highly heterogeneous disease, of which 35–50% in infant and ~ 10% in adult carry MLL-rearrangement [2–4], a genetic abnormality that leads to various MLL fusion proteins with strong oncogenic property [36].